Evo Fund lowers stake in Oncolys BioPharma to 7.93%
Stake history
Summary
Evo Fund and joint holders filed a Change in 5%+ stake (change report) via EDINET on 2024-10-18 15:21 JST concerning Oncolys BioPharma Inc. Reported holding ratio: 7.93%, previous report: 9.94%.